Monthly Communication Report

Organization:	MS Canada/SP Canada
Associated registration:	935976-14937-81
Communication date:	2026-01-20
Posted date:	2026-02-09

Designated Public Office Holders who participated in the communication:	Shalene Curtis-Micallef, Deputy Minister of Health Health Canada (HC)
List of Details Subject matter Detail Budget, Health, Research and Development, Taxation and Finance Access to treatments as it relates to the current regulatory and price negotiation processes to enhance timely access to all Health Canada approved MS disease-modifying therapies, with respect to the National Strategy for Drugs for Rare Diseases and national pharmacare. Budget, Health, Housing, Taxation and Finance Canada Health Act and regulations, as it relates to long-term and home care Budget, Employment and Training, Health, Housing, Labour, Pensions, Research and Development, Science and Technology, Taxation and Finance, Transportation Federal Budget: Allocate funding for the Canada Disability Benefit, the Employment Insurance Sickness Benefit; health research; access to treatment and care; and other budgetary policy as it relates to MS.
Responsible Officer who filed this communication report:	Pamela Valentine
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.